Landry Giardina, Sanofi’s Global Head of Clinical Supply Chain Operations Innovation & Technology talks data-driven performance, resilience, agility and operational excellence within the clinical supply chain area…
Sanofi has a mission: to chase the miracles of science to improve people’s lives, and sometimes that means starting over with Plan B, Plan C, or even Plan Z. To do so means to work across the most complex disciplines to solve problems, to push the boundaries and not be afraid to take smart risks, and to dedicate everything to making life better for people everywhere.
None of that happens without continuous and groundbreaking R&D and clinical trials to prove the medicines and vaccines it creates are safe and efficient for millions of people around the world. Which makes Landry Giardina and his colleagues’ jobs absolutely essential.
Vital experience
Landry has been at the business for close to 20 years, beginning in science-oriented roles around downstream purification and manufacturing vaccines, before making a conscious choice to move into the global clinical supply chain sector. Here he worked across several areas, including drug needs translation, heading up comparator drug sourcing, and leading digital clinical supplies, until taking his latest role – Global Head of Innovation & Technology within Clinical Supply Chain Operations – in 2022.
“It’s a digitally-focused, and innovation and performance-driven position,” says Landry, expanding on the scope of his and his team’s work. “From forecasting to operations, our role is to understand the complex needs and challenges of the clinical supply chain. Then, we translate them into operational activities to optimise supply strategy . It allows our entity to influence R&D decisions in order to optimise supply strategy, and to welcome the many new and evolving challenges the organisation faces.
“To do that effectively, I have three core teams focused on different areas: building strong foundations in robust processes, standard operating procedures and training; software and solutions management and enhancement for new projects; and lastly, implementing new technologies, tools and innovations that drive R&D in clinical trials.”
